Research Paper Volume 12, Issue 13 pp 13281—13296

SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer

Figure 5. Analyses of genetic variations in SLC7A2 in ovarian cancer (cBioPortal). (A) Genetic variations in the SLC7A2 gene reported in different studies. (B) OncoPrint overview of the genetic variations in the SLC7A2 gene. TCGA, The Cancer Genome Atlas.